Scientists test Next-Gen shot against deadly yellow fever
NCT ID NCT02743455
Summary
This was a first-in-human safety study for a new experimental yellow fever vaccine. Researchers enrolled 92 healthy adults to test the vaccine's safety and the body's immune response to it. They compared the vaccine given with and without an extra ingredient (an adjuvant) designed to boost immunity.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for YELLOW FEVER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Saint Louis University Center for Vaccine Development
St Louis, Missouri, 63104-1015, United States
-
University of Iowa - Vaccine Research and Education Unit
Iowa City, Iowa, 52242-2600, United States
Conditions
Explore the condition pages connected to this study.